Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1699
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18416749 | METHODS FOR SCREENING GENETIC PERTURBATIONS | Final Rejection | The Regents of the University of California |
| 17511187 | CHIMERIC ANTIGEN RECEPTOR (CAR) NK CELLS AND USES THEREOF | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 17819064 | CD40L EXPRESSING MAMMALIAN CELLS AND THEIR USE | Final Rejection | Hoffmann-La Roche Inc. |
| 18026474 | CELL SUPPORT AND METHOD OF PRODUCING SAME, CELL CULTURE METHOD AND CELL STRUCTURE | Non-Final OA | Konica Minolta, Inc. |
| 17549028 | PHYSIOLOGIC GROWTH OF CULTURED INTESTINAL TISSUE | Final Rejection | The Regents of the University of Michigan |
| 17757503 | T-CELL DEATH ASSOCIATED GENE 8 (TDAG8) MODULATION TO ENHANCE CELLULAR CANCER THERAPIES | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17997731 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY | Non-Final OA | Iovance Biotherapeutics, Inc. |
| 18036909 | MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF | Non-Final OA | CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION |
| 16960445 | 3D in vitro Models of Lung Tissue | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 17786255 | CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND METHODS OF MAKING AND USING SAME | Final Rejection | Washington University |
| 17495597 | MULTICELL CONJUGATES FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17606489 | ARTIFICIAL ANTIGEN PRESENTING CELLS COMPRISING LIGANDS FOR NKG2D FOR EXPANDING IMMUNE CELLS FOR IMMUNOTHERAPY | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18227001 | ADVANCED MANUFACTURED TRANSWELL USING SYNTHETIC BIOINK FOR CELL CULTURE AND IN VITRO TISSUE MODELS | Non-Final OA | Lung Biotechnology PBC |
| 18354210 | Methods for Differentiating Epithelial or Basal Cells | Non-Final OA | Lung Biotechnology PBC |
| 16321265 | DIFFERENTIATED CELL PRODUCTION METHOD AND CULTURE BAG USED THEREFOR | Final Rejection | KYOTO UNIVERSITY |
| 17996033 | TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATION | Non-Final OA | FIGENE, LLC |
| 18707061 | COMPOSITIONS AND METHODS FOR USING INDIVIDUALIZED GENOME ASSEMBLIES AND INDUCED PLURIPOTENT STEM CELL LINES OF NONHUMAN PRIMATES FOR PRE-CLINICAL EVALUATION | Non-Final OA | EXIR LLC |
| 17616200 | USES OF NAD+ AND/OR NAD+ INHIBITORS AND/OR NAD+ AGONISTS AND COMBINATION PREPARATION THEREOF | Final Rejection | ShanghaiTech University |
| 18050333 | Methods of in Vitro Cell Delivery | Non-Final OA | Intellia Therapeutics, Inc. |
| 17598916 | METHOD FOR PRODUCING CAR GENE-INTRODUCED NK CELLS AND USE THEREOF | Non-Final OA | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
| 17778611 | T-CELL MASTER CELL BANK | Final Rejection | Takeda Pharmaceutical Company Limited |
| 18328598 | NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF | Non-Final OA | Factor Bioscience Inc. |
| 17841041 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | Final Rejection | Allogene Therapeutics, Inc. |
| 17629044 | METHOD FOR PROVIDING INFORMATION NECESSARY FOR DIAGNOSING CANCER PATIENT'S RESISTANCE TO ANTI-CANCER AGENT AND/OR RADIATION | Non-Final OA | NEXT & BIO INC. |
| 16968315 | BIOPROCESSING METHODS FOR CELL THERAPY | Final Rejection | Global Life Sciences Solutions USA LLC |
| 17908857 | UP-SCALED PRODUCTION OF MICROGLIA-LIKE/-PRECURSOR CELLS AND MACROPHAGE CELLS USING MESH MACROCARRIERS | Final Rejection | RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN |
| 17704922 | METHODS FOR OBTAINING INDUCED PLURIPOTENT STEM CELLS | Final Rejection | BlueRock Therapeutics LP |
| 18015489 | METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | Non-Final OA | MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT |
| 18027306 | METHOD FOR PREPARING EFFECTOR CELLS WITH DESIRED SPECIFICITY | Non-Final OA | NATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL SCIENCE |
| 17608636 | THERAPEUTICALLY ACTIVE CELLS AND EXOSOMES | Final Rejection | Capricor, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy